Skip to main content
$286.74Today:- (-)1Y +24.95%

As of Oct 26, 2026 close

Market cap
$507.82B
P/E (TTM)
80.48
Forward P/E
47.79
Dividend yield
2.43%
52-week range
$190.75$291.40
Volume (live)
-
Avg. volume (3M)
4.84M

AbbVie (ABBV) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), AbbVie reported total assets of $133.96B and total liabilities of $137.19B. Shareholders' equity was negative at −$3.27B, meaning liabilities exceed assets. Total debt stood at $67.50B against $5.26B in cash and short-term investments, a net debt position of $62.24B.

AbbVie Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for AbbVie Inc. (ABBV) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents5.235.5212.819.209.758.4539.927.299.30
Short-Term Investments0.030.030.000.030.080.030.000.770.49
Cash & Short-Term Investments5.265.5612.829.239.838.4839.928.069.79
Accounts Receivable12.5910.9211.1611.259.988.825.435.385.09
Inventory4.954.184.103.583.133.311.811.611.61
Other Current Assets6.274.934.934.404.993.562.351.904.74
Total Current Assets29.0625.5833.0028.4627.9324.1749.5216.9521.22
Non-Current Assets
Property, Plant & Equipment (Net)5.635.134.994.945.115.252.962.882.80
Long-Term Investments0.300.280.300.240.280.290.091.422.09
Goodwill35.6434.9632.2932.1632.3833.1215.6015.6615.79
Intangible Assets52.6460.0755.6167.4475.9582.8818.6521.2327.56
Other Non-Current Assets10.729.148.515.574.884.852.291.211.33
Total Non-Current Assets104.90109.58101.71110.34118.60126.3939.6042.4149.56
Total Assets133.96135.16134.71138.81146.53150.5789.1259.3570.79
Current Liabilities
Accounts Payable3.592.953.6925.402.882.281.451.551.47
Short-Term Debt8.566.807.190.0012.678.683.755.316.42
Current Portion of Long-Term Debt6.066.807.194.1412.48----
Accrued Liabilities28.0426.0624.1812.509.02----
Deferred Revenue0.0014.300.0010.720.000.000.000.000.00
Other Current Liabilities30.9512.0126.969.7919.6417.7110.3810.398.75
Total Current Liabilities43.2938.7537.8429.5435.1928.6615.5917.2416.64
Non-Current Liabilities
Long-Term Debt58.9460.3452.9359.1464.9078.3963.2535.0030.95
Deferred Tax Liabilities2.392.588.632.198.989.333.903.795.17
Other Non-Current Liabilities30.8027.6324.9132.8522.0221.1014.5711.7612.92
Total Non-Current Liabilities93.9093.0586.4791.9895.90108.8181.7050.5649.05
Total Liabilities137.19131.80124.31121.52131.09137.4797.2967.8065.69
Stockholders' Equity
Common Stock0.020.020.020.020.020.020.020.020.02
Retained Earnings-15.49-7.90-1.004.783.131.064.723.375.46
Accumulated Other Comprehensive Income-1.14-1.93-2.31-2.20-2.90-3.12-3.60-2.48-2.73
Treasury Stock9.158.206.534.593.14----
Additional Paid-in Capital22.5021.3313.6519.2515.1615.12-9.31-9.352.35
Minority Interest0.040.040.040.030.030.020.000.000.00
Shares Outstanding1.771.771.771.771.77----
Total Stockholders' Equity-3.273.3310.3617.2915.4113.08-8.17-8.455.10
Total Liabilities & Equity133.96135.16134.71138.81146.53150.5789.1259.3570.79

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AbbVie Balance Sheet

How much debt does AbbVie have?

AbbVie had total debt of $67.50B as of Dec 31, 2025, against $5.26B in cash and short-term investments. Total debt was $67.14B a year earlier.

What are AbbVie's total assets?

AbbVie reported total assets of $133.96B as of Dec 31, 2025, down 0.9% from $135.16B a year earlier. Total liabilities were $137.19B.

What is AbbVie's shareholders' equity?

AbbVie's shareholders' equity was negative at −$3.27B as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition